Literature DB >> 7272584

Interactions between hydralazine, propildazine and purines on arterial smooth muscle.

C Chevillard, B Saiag, M Worcel.   

Abstract

1 The interaction of hydralazine (Hyd) and propildazine (Pyd) with purine compounds was studied in the isolated tail artery from normotensive Wistar (NW) rats.2 Exogenously added purines inhibit non competitively the antispasmogenic response to Hyd in denervated NW segments. The order of potency is 2-Cl-adenosine > adenosine > adenosine 5'-triphosphate (ATP) > inosine. Pyd action is modified only by the most active purine 2-Cl-adenosine, which displaces the dose-response curves to the right. Hyd and Pyd seem to act on the same site, since their maximal effects are not additive.3 Theophylline (Theo) 50 muM induces the appearance of the antispasmogenic effect of Hyd in the usually poorly responsive innervated proximal NW arterial segments. The potentiating action of Theo is identical to the enhancement of the Hyd response observed after 6-hydroxydopamine denervation. This result suggests that the release of endogenous purines from sympathetic nerves is sufficient to block the smooth muscle responses to Hyd, under our experimental conditions. A similar potentiating effect is obtained with propranolol (5 muM).4 The spontaneous release of (3)H, after loading with [(3)H]-noradrenaline, was considered as an indirect indication of purine leakage from nerve terminals. There is an inverse relationship between the rate of (3)H release, under these conditions, and the magnitude of the relaxant response to Hyd, i.e., (3)H leakage is higher in proximal NW segments.5 The most satisfactory explanation for the interaction of Hyd and Pyd with exogenous purines, and for the modulating actions of sympathetic nerve terminals, is that both antihypertensives act on a common receptor, sensitive to endogenous ATP and adenosine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272584      PMCID: PMC2071486          DOI: 10.1111/j.1476-5381.1981.tb08733.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Isolation and radioenzymic estimation of picogram quantities of dopamine and norepinephrine in biological samples.

Authors:  C Gauchy; J P Tassin; J Glowinski; A Cheramy
Journal:  J Neurochem       Date:  1976-03       Impact factor: 5.372

2.  Possible involvement of a transmitter different from norepinephrine in the residual responses to nerve stimulation of the cat nictitating membrane after pretreatment with reserpine.

Authors:  S Z Langer; J E Pinto
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

3.  Cyclic AMP as a mediator of the relaxing action of papaverine, nitroglycerine, diazoxide and hydralazine in intestinal and vascular smooth muscle.

Authors:  R Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

4.  Noradrenaline storage particles in splenic nerve.

Authors:  W P De Potter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1971-06-17       Impact factor: 6.237

5.  Relationship between the direct inhibitory effect of hydralazine and propildazine on arterial smooth muscle contractility and sympathetic innervation.

Authors:  M Worcel
Journal:  J Pharmacol Exp Ther       Date:  1978-11       Impact factor: 4.030

6.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

7.  Adrenergic neuronal degeneration induced in portal vein and caudal artery by 6-hydroxydopamine in vitro.

Authors:  O Aprigliano; K E Rybarczyk; K Hermsmeyer; L S Van Orden
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

8.  Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides.

Authors:  R H Verhaeghe; P M Vanhoutte; J T Shepherd
Journal:  Circ Res       Date:  1977-02       Impact factor: 17.367

9.  The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens.

Authors:  D P Westfall; R E Stitzel; J N Rowe
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

10.  Neurogenic release of purine compounds in blood vessels.

Authors:  C Su
Journal:  J Pharmacol Exp Ther       Date:  1975-10       Impact factor: 4.030

View more
  2 in total

1.  Disposition and pharmacokinetics of cadralazine and individual metabolites in man.

Authors:  H Schütz; J W Faigle; W Küng; W Theobald
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

2.  Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens.

Authors:  D W Hay; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.